Sartorius Stedim Biotech SA updates its share capital and voting rights

Sartorius Stedim Biotech SA has published a statement regarding the number of shares and voting rights that make up its share capital as of February 29, 2024. According to the document, the company has reached a total number of 97,330,405 shares. Theoretical voting rights amount to 165,579,858, taking into account the company's treasury shares. Net voting rights, meanwhile, are slightly lower, amounting to 165,562,569.

This regulatory update, transmitted via EQS Group, is part of the company's legal obligations under article L 233-8-II of the Commercial Code and article 223-6 of the general regulations of the AMF. The announcement serves to inform stakeholders and investors about the current capital structure of Sartorius Stedim Biotech SA, a key player in the biotechnology sector.